IRDNasdaq

Opus Genetics, Inc.

Alert me on IRD

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Oct 3 Sale Foundation Fighting Blindness Retinal Degeneration Fund Insider

1 week

+5.9%S&P +0.4%

1 month

Result in7 trading days

3 months

Result in49 trading days

6 months

Result in112 trading days

Oct 3 Sale Foundation Fighting Blindness, Inc. Insider

1 week

+5.9%S&P +0.4%

1 month

Result in7 trading days

3 months

Result in49 trading days

6 months

Result in112 trading days

Sep 9 Sale Gagnon Robert E. Insider

1 week

−5.6%S&P −1.1%

1 month

−22.2%S&P +1.8%

3 months

Result in31 trading days

6 months

Result in94 trading days

Jul 28 Sale Magrath George Insider

1 week

+8.8%S&P +4.1%

1 month

+11.4%S&P +3.4%

3 months

Result in1 trading day

6 months

Result in64 trading days

Jul 28 Sale SCHACHLE JOSEPH K Insider

1 week

+8.8%S&P +4.1%

1 month

+11.4%S&P +3.4%

3 months

Result in1 trading day

6 months

Result in64 trading days

Show all 22

Jul 28 Sale Gagnon Robert E. Insider

1 week

+8.8%S&P +4.1%

1 month

+11.4%S&P +3.4%

3 months

Result in1 trading day

6 months

Result in64 trading days

Jul 28 Sale YERXA BENJAMIN R Insider

1 week

+8.8%S&P +4.1%

1 month

+11.4%S&P +3.4%

3 months

Result in1 trading day

6 months

Result in64 trading days

May 21 Sale Foundation Fighting Blindness Retinal Degeneration Fund Insider

1 week

+1.6%S&P +1.9%

1 month

−4.9%S&P −1.0%

3 months

−5.6%S&P +3.4%

6 months

Result in19 trading days

May 21 Sale Foundation Fighting Blindness, Inc. Insider

1 week

+1.6%S&P +1.9%

1 month

−4.9%S&P −1.0%

3 months

−5.6%S&P +3.4%

6 months

Result in19 trading days

Apr 28 Sale Gagnon Robert E. Insider

1 week

+4.0%S&P +1.7%

1 month

−16.0%S&P +6.0%

3 months

−30.6%S&P +2.8%

6 months

Result in2 trading days

Apr 28 Sale Zaremba Rabourn Amy Insider

1 week

+4.0%S&P +1.7%

1 month

−16.0%S&P +6.0%

3 months

−30.6%S&P +2.8%

6 months

Result in2 trading days

Apr 28 Sale Magrath George Insider

1 week

+4.0%S&P +1.7%

1 month

−16.0%S&P +6.0%

3 months

−30.6%S&P +2.8%

6 months

Result in2 trading days

Apr 28 Sale SCHACHLE JOSEPH K Insider

1 week

+4.0%S&P +1.7%

1 month

−16.0%S&P +6.0%

3 months

−30.6%S&P +2.8%

6 months

Result in2 trading days

Apr 28 Sale YERXA BENJAMIN R Insider

1 week

+4.0%S&P +1.7%

1 month

−16.0%S&P +6.0%

3 months

−30.6%S&P +2.8%

6 months

Result in2 trading days

Apr 28 Sale Jayagopal Ashwath Insider

1 week

+4.0%S&P +1.7%

1 month

−16.0%S&P +6.0%

3 months

−30.6%S&P +2.8%

6 months

Result in2 trading days

Mar 19 Sale Jayagopal Ashwath Insider

1 week

−1.3%S&P −2.0%

1 month

+21.0%S&P +7.7%

3 months

−11.1%S&P +13.8%

6 months

+13.1%S&P +16.3%

Mar 19 Sale Zaremba Rabourn Amy Insider

1 week

−1.3%S&P −2.0%

1 month

+21.0%S&P +7.7%

3 months

−11.1%S&P +13.8%

6 months

+13.1%S&P +16.3%

Mar 19 Sale SCHACHLE JOSEPH K Insider

1 week

−1.3%S&P −2.0%

1 month

+21.0%S&P +7.7%

3 months

−11.1%S&P +13.8%

6 months

+13.1%S&P +16.3%

Mar 19 Sale Magrath George Insider

1 week

−1.3%S&P −2.0%

1 month

+21.0%S&P +7.7%

3 months

−11.1%S&P +13.8%

6 months

+13.1%S&P +16.3%

Jan 1 Buy Gallagher Cam Insider

1 week

−9.0%S&P +1.6%

1 month

+13.2%S&P +0.9%

3 months

+117.5%S&P −3.3%

6 months

+91.0%S&P +10.0%

Dec 12, 2025 Sale Foundation Fighting Blindness Retinal Degeneration Fund Insider

1 week

−15.3%S&P +0.1%

1 month

−8.1%S&P +1.6%

3 months

+103.4%S&P −1.3%

6 months

+65.3%S&P +10.7%

Dec 12, 2025 Sale Foundation Fighting Blindness, Inc. Insider

1 week

−15.3%S&P +0.1%

1 month

−8.1%S&P +1.6%

3 months

+103.4%S&P −1.3%

6 months

+65.3%S&P +10.7%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for IRD

74 held · newest 574 held · newest 2

Loading the filings.

See all 74 filings for IRD

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Jun 30, 2026 Schedule 13G, amended

Perceptive Advisors LLC: 10%, 9,233,710 shares

Jun 30, 2026 Schedule 13G, amended

Caligan Partners LP: 7.3%, 6,077,084 shares

Jun 30, 2026 Schedule 13G, amended

BALYASNY ASSET MANAGEMENT L.P.: 6.6%, 5,480,210 shares

May 18, 2026 Schedule 13D, amended

Foundation Fighting Blindness Retinal Degeneration Fund: 4.7%, 3,792,171 shares

Mar 31, 2026 Schedule 13G, amended

Nantahala Capital Management, LLC: 6.5%, 4,839,225 shares

Mar 31, 2026 Schedule 13G, amended

Perceptive Advisors LLC: 10%, 8,830,145 shares

Mar 31, 2026 Schedule 13G

Caligan Partners LP: 8.5%, 6,075,028 shares

Mar 31, 2026 Schedule 13G, amended

Balyasny Asset Management L.P.: 7.2%, 5,110,373 shares

May 12, 2026 Schedule 13G, amended

AARON G.L. FLETCHER: 4.5%, 3,683,429 shares

Mar 31, 2026 Schedule 13G

Adage Capital Management, L.P.: 8.5%, 6,029,775 shares

Dec 31, 2025 Schedule 13G, amended

Perceptive Advisors LLC: 10%, 7,174,154 shares

Dec 31, 2025 Schedule 13G

Balyasny Asset Management L.P.: 7.4%, 5,110,373 shares

Dec 31, 2025 Schedule 13G, amended

Nantahala Capital Management, LLC: 10%, 7,123,506 shares

Dec 9, 2025 Schedule 13D, amended

Foundation Fighting Blindness Retinal Degeneration Fund: 8%, 5,492,171 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

NoneQ4 2025

$15KQ1 2026

$15KQ2 2026

$15KQ3 2026

Unchanged from Q2 2026. Reported to the Senate each quarter by the firms it hires.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 20, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.